Literature DB >> 32526241

Berbamine induced AMPK activation regulates mTOR/SREBP-1c axis and Nrf2/ARE pathway to allay lipid accumulation and oxidative stress in steatotic HepG2 cells.

Ankita Sharma1, Sumit Kr Anand2, Neha Singh2, Upendra Nath Dwivedi3, Poonam Kakkar4.   

Abstract

Non-alcoholic fatty liver disease is emanating as a global cataclysm. This study was designed to investigate the antioxidative, anti-inflammatory and fat metabolism-regulating potential of berbamine (BBM), a natural bis-benzylisoquinoline alkaloid. BBM attenuated intracellular lipid accumulation in oleic-acid exposed HepG2 cells (0.5 mM) by inhibiting fatty acid uptake, lipogenesis, and promoting fatty acid β-oxidation by activating AMP-activated kinase (AMPK) and peroxisome proliferator-activated receptor (PPAR)-α. Berbamine (5 μM) induced AMPK activation (P < 0.001) via LKB1 (Ser-428) and elevated AMP:ATP ratio (P < 0.001). AMPK activation negatively regulated mTOR and also constrained the nuclear translocation of SREBP-1c and inhibited the lipogenic proteins, stearoyl-CoA desaturase-1 (SCD-1) and fatty acid synthase (FAS) (P < 0.001). BBM stimulated nuclear translocation of redox-sensitive nuclear factor erythroid-2-related factor-2 (Nrf2) and increased hepatic expression of Nrf2 responsive enzymes, HO-1 and Nqo-1. BBM treatment reduced the oxidative burst and pro-inflammatory responses by significantly enhancing hepatic antioxidant defenses [SOD (P < 0.001), catalase (P < 0.001) and cellular glutathione (P < 0.01)] and diminishing NF-κB regulated pro-inflammatory cytokines (TNF-α, and IL-6) levels respectively. TEM analysis confirmed the disruption of mitochondrial structure and reduction in mitochondrial size (50.97%, P < 0.001) in steatotic HepG2 cells which was significantly prevented by 5 μM BBM treatment (71.84% as compared to control, P < 0.01). Pre-treatment of Compound C (AMPK inhibitor, 25 μM) greatly repressed the anti-steatotic properties exhibited by BBM confirming the involvement of AMPK signaling pathway. In summary, the results manifest that BBM reduces intracellular lipid accumulation via AMPK/mTOR/SREBP-1c axis mediated regulation of lipid metabolism and upsurged nuclear stability of Nrf2 by promoting AMPK/Nrf2 association to ameliorate oxidative stress/proinflammatory response.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AMPK; Lipogenic proteins; Nrf2; SREBP-1c; Steatosis

Mesh:

Substances:

Year:  2020        PMID: 32526241     DOI: 10.1016/j.ejphar.2020.173244

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  The Dibenzyl Isoquinoline Alkaloid Berbamine Ameliorates Osteoporosis by Inhibiting Bone Resorption.

Authors:  Chongjing Zhang; Zeyuan Zhong; Weicong Sang; Farnaz Ghorbani; Behafarid Ghalandari; Marjan Mohamadali; Shiva Irani; Zhi Qian; Chengqing Yi; Baoqing Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-18       Impact factor: 6.055

Review 2.  AMP-Activated Protein Kinase: Do We Need Activators or Inhibitors to Treat or Prevent Cancer?

Authors:  Fiona M Russell; David Grahame Hardie
Journal:  Int J Mol Sci       Date:  2020-12-27       Impact factor: 5.923

3.  Effect of Quercetin on Lipids Metabolism Through Modulating the Gut Microbial and AMPK/PPAR Signaling Pathway in Broilers.

Authors:  Mi Wang; Bo Wang; Shanshan Wang; Han Lu; Hao Wu; Manyi Ding; Linlin Ying; Yanjun Mao; Yao Li
Journal:  Front Cell Dev Biol       Date:  2021-02-09

4.  Nischarin Deletion Reduces Oxidative Metabolism and Overall ATP: A Study Using a Novel NISCHΔ5-6 Knockout Mouse Model.

Authors:  Tina H Nguyen; Hassan Yousefi; Samuel C Okpechi; Lothar Lauterboeck; Shengli Dong; Qinglin Yang; Suresh K Alahari
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 6.208

5.  Effects of berbamine against myocardial ischemia/reperfusion injury: Activation of the 5' adenosine monophosphate-activated protein kinase/nuclear factor erythroid 2-related factor pathway and changes in the mitochondrial state.

Authors:  Chennian Xu; Yang Liu; Jian Yang; Mengen Zhai; Zhenge Fan; Rui Qiao; Ping Jin; Lifang Yang
Journal:  Biofactors       Date:  2022-02-07       Impact factor: 6.438

6.  Quantitative Profiling of Oxylipin Reveals the Mechanism of Pien-Tze-Huang on Alcoholic Liver Disease.

Authors:  Ziye Zhu; Wenjun Zhou; Yang Yang; Kai Wang; Fenghua Li; Yanqi Dang
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-01       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.